Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest/Almirall's COPD drug filed in USA
Pharma Times, UK
Thursday, June 30, 2011 - 9:35am
tags:
Forest Labs, Almirall, COPD, FDA, aclidinium
Congress Widens Probe Into The Heparin Scandal
Pharmalot
Thursday, June 30, 2011 - 9:34am
tags:
congress, Heparin, FDA, China
Corcept Therapeutics says FDA will make decision on Cushing's Syndrome drug Corlux by Feb. 17
Yahoo/AP
Thursday, June 30, 2011 - 9:31am
tags:
Corcept Therapeutics, FDA, Cushing's disease, Corlux
VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction
Yahoo
Thursday, June 30, 2011 - 8:18am
tags:
Vivus, Avanafil, erectile dysfunction
The Diabetes Trade: Why We Like Amylin
Seeking Alpha
Thursday, June 30, 2011 - 8:02am
tags:
diabetes, Amylin
BioCryst files for $70M shelf offering
Bizjournals.com
Thursday, June 30, 2011 - 7:47am
tags:
stock offering, Biocryst
Ziopharm: Small Molecules Meet Next-Generation Synthetic Biology
Seeking Alpha
Thursday, June 30, 2011 - 7:46am
tags:
Ziopharm
Top Drug Stocks
Investopedia
Thursday, June 30, 2011 - 7:45am
tags:
Abbott Laboratories, Allergan, Novartis, Pfizer, PowerShares
Eli Lilly Plans 10 Drugs in Final-Stage Trials by End of 2011
Bloomberg
Thursday, June 30, 2011 - 7:42am
tags:
Eli Lilly, pipelines, R&D
Peregrine Pharma's Secret Weapon
Minyanville
Wednesday, June 29, 2011 - 10:46pm
tags:
Peregrine Pharmaceuticals
Is Affymetrix a Cash King?
Motley Fool
Wednesday, June 29, 2011 - 10:45pm
tags:
Affymetrix
Health care reform law passes first appeals test
Bizjournals.com
Wednesday, June 29, 2011 - 7:47pm
tags:
healthcare reform
Federal panel says government should revoke cancer drug Avastin's approval for breast cancer
Yahoo/AP
Wednesday, June 29, 2011 - 7:46pm
tags:
Avastin, advisory panels, breast cancer, FDA, Roche
Novartis Afinitor Backed in EU
Yahoo/Zacks.com
Wednesday, June 29, 2011 - 7:45pm
tags:
Novartis, Afinitor, Europe, ONYX Pharmaceuticals, Pfizer, brain tumors
Icahn sues Forest for info on Solomon's woes
Fierce Pharma
Wednesday, June 29, 2011 - 10:48am
tags:
Forest Labs, Carl Icahn
Biotechs are looking at a new normal
Boston Globe, MA
Wednesday, June 29, 2011 - 10:27am
tags:
biotech
Biotech Data Mining Comes Up Empty
TheStreet.com
Wednesday, June 29, 2011 - 10:26am
tags:
data mining, Cel-Sci, Apricus Biosciences, Osiris, Transdel, Agenus, Introgen, Cell Therapeutics
Human Genome Sciences’ Watkins elected BIO chair
Bizjournals.com
Wednesday, June 29, 2011 - 10:23am
tags:
BIO, Human Genome Sciences, Thomas Watkins, Pharma CEOs
Newron, Merck Serono conclude patient recruitment in Phase III MOTION study
Pharmaceutical Business Review
Wednesday, June 29, 2011 - 7:30am
tags:
Newron Pharma, Merck Serono, Parkinson's Disease
Medivir: terms of herpes-drug venture are reset
Marketwatch
Wednesday, June 29, 2011 - 6:57am
tags:
herpes, Medivir, Xerese, Meda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.